A Phase I Clinical Trial of Hepatic Arterial Infusion of Oxaliplatin, Oral Capecitabine, With or Without Systemic Bevacizumab for Patients With Advanced Cancer Metastatic to the Liver.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Bevacizumab
- Indications Cancer; Liver metastases
- Focus Adverse reactions
- 14 Mar 2018 Planned End Date changed from 1 Sep 2022 to 1 Sep 2023.
- 08 Oct 2010 New trial record